Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGSWW) Accounts Payables (2020 - 2025)

GeneDx Holdings has reported Accounts Payables over the past 6 years, most recently at $57.6 million for Q4 2025.

  • Quarterly results put Accounts Payables at $57.6 million for Q4 2025, up 86.05% from a year ago — trailing twelve months through Dec 2025 was $57.6 million (up 86.05% YoY), and the annual figure for FY2025 was $57.6 million, up 86.05%.
  • Accounts Payables for Q4 2025 was $57.6 million at GeneDx Holdings, up from $50.3 million in the prior quarter.
  • Over the last five years, Accounts Payables for WGSWW hit a ceiling of $115.9 million in Q2 2022 and a floor of $31.0 million in Q4 2024.
  • Median Accounts Payables over the past 5 years was $49.8 million (2025), compared with a mean of $55.2 million.
  • Biggest five-year swings in Accounts Payables: soared 223815.85% in 2021 and later plummeted 55.87% in 2023.
  • GeneDx Holdings' Accounts Payables stood at $44.7 million in 2021, then skyrocketed by 89.91% to $84.9 million in 2022, then crashed by 55.87% to $37.5 million in 2023, then fell by 17.28% to $31.0 million in 2024, then surged by 86.05% to $57.6 million in 2025.
  • The last three reported values for Accounts Payables were $57.6 million (Q4 2025), $50.3 million (Q3 2025), and $49.2 million (Q2 2025) per Business Quant data.